A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Prostate Cancer
Interventions
DRUG

123I-MIP-1072

Single IV dose

Trial Locations (1)

20892

CCR/NCI - Molecular Imaging Program, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY